J. Fernando Mandujano

Pulmonary Associates — United States

Immunology and Microbiology · Life Sciences

4h-index40citations5works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunodeficiency and Autoimmune Disorders(5), Blood disorders and treatments(4), Cystic Fibrosis Research Advances(2), Pediatric health and respiratory diseases(2), Pneumonia and Respiratory Infections(1)

Publications5 total

Corrigendum: Clinical efficacy, safety and tolerability of a new subcutaneous immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the treatment of patients with primary immunodeficiencies
Frontiers in Immunology·2022Open Access
Long-term efficacy, safety, and tolerability of a subcutaneous immunoglobulin 16.5% (cutaquig®) in the treatment of patients with primary immunodeficiencies
Clinical & Experimental Immunology·2022· 9 citedOpen Access
Efficacy, Safety and Tolerability of a New 10% Intravenous Immunoglobulin for the Treatment of Primary Immunodeficiencies
Frontiers in Immunology·2021· 4 citedOpen Access
Treatment of Children with Primary Immunodeficiencies with a Subcutaneous Immunoglobulin 16.5% (Cutaquig <sup>®</sup>  [Octanorm])
Immunotherapy·2021· 5 citedOpen Access
Clinical Efficacy, Safety and Tolerability of a New Subcutaneous Immunoglobulin 16.5% (Octanorm [Cutaquig®]) in the Treatment of Patients With Primary Immunodeficiencies
Frontiers in Immunology·2019· 22 citedOpen Access

Frequent Co-authors

Roger H. Kobayashi(4), Ai Kobayashi(4), Bob Geng(4), T. Prescott Atkinson(4), Eva Turpel-Kantor(4), Sudhir Gupta(3), Isaac Melamed(3), Bruce Ritchie(3), Syed Shakil Ur Rehman(3), Jiří Litzman(3), Sonja Höller(1), Huub T. C. Kreuwel(1), J C Speer(1), Syed M. Rehman(1), Elisabeth Clodi(1), Elena Pérez(1), Jacques Hébert(1), Anne K. Ellis(1), Oral Alpan(1), William R. Lumry(1)